Insider Transactions in Q2 2022 at Salarius Pharmaceuticals, Inc. (SLRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2022
|
Jonathan I Lieber Director |
BUY
Open market or private purchase
|
Direct |
37,500
+50.0%
|
$0
$0.19 P/Share
|
|
Jun 07
2022
|
Tess Burleson Director |
BUY
Open market or private purchase
|
Direct |
27,700
+46.36%
|
$0
$0.18 P/Share
|
|
Jun 06
2022
|
William K. Mc Vicar Director |
BUY
Open market or private purchase
|
Indirect |
26,553
+50.0%
|
$0
$0.19 P/Share
|
|
Jun 03
2022
|
Arnold C Hanish Director |
BUY
Open market or private purchase
|
Indirect |
28,000
+37.66%
|
$0
$0.18 P/Share
|
|
May 31
2022
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Open market or private purchase
|
Direct |
28,000
+15.88%
|
$0
$0.18 P/Share
|
|
May 26
2022
|
David J. Arthur Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
21,900
+2.37%
|
$0
$0.18 P/Share
|
|
May 26
2022
|
David J. Arthur Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
22,000
+3.74%
|
$0
$0.18 P/Share
|
|
May 03
2022
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.67%
|
$0
$0.19 P/Share
|
|
May 03
2022
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+3.71%
|
$0
$0.19 P/Share
|